Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. China
  4. Shenzhen Stock Exchange
  5. Shanghai Xuerong Biotechnology Co.,Ltd.
  6. Summary
    300511   CNE100002706

SHANGHAI XUERONG BIOTECHNOLOGY CO.,LTD.

(300511)
  Report
End-of-day quote Shenzhen Stock Exchange  -  05-17
6.320 CNY   -0.63%
04/27Shanghai Xuerong Biotechnology Co.,Ltd. Announces Final Cash Dividend Proposal for 2021
CI
04/26Shanghai Xuerong Biotechnology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
03/15Shanghai Xuerong Biotechnology Co.,Ltd. announced that it has received CNY 397.999996 million in funding
CI
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Shenzhen Stock Exchange
05/12/2022 05/13/2022 05/16/2022 05/17/2022 05/18/2022 Date
6.35 6.36 6.58 6.36 6.32 Last
9107065 6839905 17520700 11970630 7977600 Volume
0.00% +0.16% +3.46% -3.34% -0.63% Change
Estimated financial data (e)
More Financials
Company
Shanghai Xuerong Biotechnology Co.,Ltd. is a China-based modern agricultural company principally engaged in the production of factory cultivated agricultural products. The Company is mainly engaged in the research and development, factory cultivation and sale of fresh edible mushrooms. The Company's main products include enoki mushrooms, hypsizygus tessellatus (including beech mushrooms, white beech mushrooms and... 
Read more
Sector
Fishing & Farming
Calendar
09/01Earnings Release
More about the company
All news about SHANGHAI XUERONG BIOTECHNOLOGY CO.,LTD.
04/27Shanghai Xuerong Biotechnology Co.,Ltd. Announces Final Cash Dividend Proposal for 2021
CI
04/26Shanghai Xuerong Biotechnology Co.,Ltd. Reports Earnings Results for the First Quarter ..
CI
03/15Shanghai Xuerong Biotechnology Co.,Ltd. announced that it has received CNY 397.999996 m..
CI
2021Yinwan Huayi No. 1 Private Securities Investment Fund managed by Zhejiang Invest Equity..
CI
2021Shanghai Xuerong Biotechnology Co., Ltd. Reports Earnings Results for the Half Year End..
CI
2021Shanghai Xuerong Biotechnology Co.,Ltd. Announces to Implement Final Cash Distribution ..
CI
2021Shanghai Xuerong Biotechnology Co., Ltd. Approves Cash Dividend for the Year 2020
CI
2021Shanghai Xuerong Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter..
CI
2021Shanghai Xuerong Biotechnology Co., Ltd. Announces Final Cash Dividend for the Year 202..
CI
2021Shanghai Xuerong Biotechnology Co., Ltd. Reports Earnings Results for the Full Year End..
CI
2020Shanghai Juhui Biopharmaceutical Industrial Development Co., Ltd. entered into a share ..
CI
2020Shanghai Xuerong Biotechnology Co., Ltd. announced that it expects to receive CNY 2.25 ..
CI
2020Vesta Food Lab announced that it has received CNY 16.1 million in funding from Shanghai..
CI
2020Shanghai Xuerong Biotechnology Co.,Ltd. Announces Management Changes
CI
2020Vesta Food Lab announced that it expects to receive CNY 16.1 million in funding from Sh..
CI
More news
News in other languages on SHANGHAI XUERONG BIOTECHNOLOGY CO.,LTD.
04/27Shanghai Xuerong Biotechnology Co.,Ltd. annonce une proposition finale de dividende en ..
04/26Shanghai Xuerong Biotechnology Co.,Ltd. annonce ses résultats pour le premier trimestre..
2021Shanghai Xuerong Biotechnology Co.,Ltd. annonce la mise en place d'un plan de distribut..
2021Shanghai Xuerong Biotechnology Co., Ltd. approuve un dividende en espèces pour l'année ..
2021Shanghai Xuerong Biotechnology Co., Ltd. annonce un dividende final en espèces pour l'a..
More news
Chart SHANGHAI XUERONG BIOTECHNOLOGY CO.,LTD.
Duration : Period :
Shanghai Xuerong Biotechnology Co.,Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SHANGHAI XUERONG BIOTECHNOLOGY CO.,LTD.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Mean consensus -
Number of Analysts 0
Last Close Price 6,32
Average target price
Spread / Average Target -
EPS Revisions
Managers and Directors
Yong Ping Yang Chairman & General Manager
Yong Lu Chairman-Supervisory Board
Ye Wei Independent Director
Zhan Gang Sun Independent Director
Huan Cheng Zhu Director & Deputy General Manager
Sector and Competitors
1st jan.Capi. (M$)
SHANGHAI XUERONG BIOTECHNOLOGY CO.,LTD.-16.62%479
VILMORIN & CIE-19.12%1 046
MISSION PRODUCE, INC.-15.73%985
COSTA GROUP HOLDINGS LIMITED-0.66%981
APPHARVEST, INC.-26.22%323
ALICO, INC.12.56%315